Targeting Carnitine Biosynthesis: Discovery of New Inhibitors Against Gamma-Butyrobetaine Hydroxylase.
Tars, K., Leitans, J., Kazaks, A., Zelencova, D., Liepinsh, E., Kuka, J., Makrecka, M., Lola, D., Andrianovs, V., Gustina, D., Grinberga, S., Liepinsh, E., Kalvinsh, I., Dambrova, M., Loza, E., Pugovics, O.(2014) J Med Chem 57: 2213
- PubMed: 24571165 
- DOI: 10.1021/jm401603e
- Primary Citation of Related Structures:  
4C5W, 4BG1, 4BGK, 4BGM, 4BHF, 4BHI - PubMed Abstract: 
γ-Butyrobetaine hydroxylase (BBOX) catalyzes the conversion of gamma butyrobetaine (GBB) to l-carnitine, which is involved in the generation of metabolic energy from long-chain fatty acids. BBOX inhibitor 3-(1,1,1-trimethylhydrazin-1-ium-2-yl)propanoate (mildronate), which is an approved, clinically used cardioprotective drug, is a relatively poor BBOX inhibitor and requires high daily doses ...